ITRM vs LYB · rev $390.0K vs P/E 21, rev $40.30B
Iterum Therapeutics PLC (ITRM) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
ITRM currently screens at market cap $38.6M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the ITRM and LYB stock pages for the full models.
Not investment advice.